Skip to main content
Equibles

ALGERT GLOBAL LLC

Position in RYTM — Rhythm Pharmaceuticals, Inc.

CIK 1275218 SAN FRANCISCO, CA
Back to RYTM Full portfolio

Position in RYTM

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$9,263,343
+$4,174,468 QoQ
Shares Held
83,431
+42.6% QoQ
Ownership
0.121%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RYTM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ALGERT GLOBAL LLC holds $633,232,925 across 110 Biotechnology names. RYTM ranks #24 (1.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PCVX
Vaxcyte, Inc.
 515,343 $29,956,888
2 ROIV
Roivant Sciences Ltd.
 845,118 $29,908,726
3 XENE
Xenon Pharmaceuticals Inc.
 419,773 $25,337,498
4 CLDX
Celldex Therapeutics, Inc.
 647,836 $24,105,977
5 AXSM
Axsome Therapeutics, Inc.
 95,335 $23,335,147
6 SNDX
Syndax Pharmaceuticals Inc
 1,051,465 $22,985,024
7 MRNA
Moderna, Inc.
 274,820 $19,245,644
8 MLYS
Mineralys Therapeutics, Inc.
 649,027 $17,510,748

All Filings in RYTM

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,263,343 83,431
2026-03-31 $5,088,875 58,513
2025-12-31 $9,446,280 88,250
2025-09-30 $14,167,281 140,284
2025-06-30 $3,805,238 60,219
2025-03-31 $3,255,589 61,461
2024-12-31 $2,326,024 41,551
2024-09-30 $2,838,018 54,171
2024-06-30 $4,275,659 104,132
2024-03-31 $2,991,849 69,048
2023-12-31 $1,324,073 28,803
2023-09-30 $765,993 33,413
2023-06-30 $974,443 59,093
2020-12-31 $359,138 12,080